| Ethiopian Infections Rate Rose By 26 Percent. |
| "The vision which fueled our struggle for freedom… will be needed if we are to bring AIDS under control. This is a war." Former South African President Nelson Mandela, February 2002 |
October 7, 2007
A new report conducted by Ethiopia’s Federal
HIV/AIDS Control Office (FAPCO) reveals that new
HIV infections there have increased 26 percent
compared to data collected at the beginning of this
year.
In the first phase of the study, from November 2006
through January 2007, researchers found that
37,943 Ethiopians were HIV positive, representing
5.4 percent of the total population. The second
phase, which ended in August 2007, showed that
70,470 people (7.3 percent of the population) were
living with HIV.
While FAPCO’s Millennium AIDS Campaign aimed to
test 1.8 million Ethiopians from January through July
of this year, only 982,452 people were tested.
According to Dr. Yibeltal Assefa, health program
officer at HAPCO, 3 million testing kits have been
prepared for the new year.
A new report conducted by Ethiopia’s Federal
HIV/AIDS Control Office (FAPCO) reveals that new
HIV infections there have increased 26 percent
compared to data collected at the beginning of this
year.
In the first phase of the study, from November 2006
through January 2007, researchers found that
37,943 Ethiopians were HIV positive, representing
5.4 percent of the total population. The second
phase, which ended in August 2007, showed that
70,470 people (7.3 percent of the population) were
living with HIV.
While FAPCO’s Millennium AIDS Campaign aimed to
test 1.8 million Ethiopians from January through July
of this year, only 982,452 people were tested.
According to Dr. Yibeltal Assefa, health program
officer at HAPCO, 3 million testing kits have been
prepared for the new year.
| One in 20 people there is HIV positive. |
October 8, 2007
This year’s crop of incoming college students may
have heard plenty about HIV throughout their lives—
but they still might not make prevention a personal
priority, NPR reports.
At a recent meeting at Howard University in
Washington, DC, UNAIDS director Dr. Peter Piot
urged students to become informed about the virus—
and to realize that the global AIDS epidemic is far
from over. He also addressed DC’s high HIV-
infection rate: One in 20 people there is HIV positive.
According to an American College Health
Association study, HIV prevalence among college
students last year was nearly equal to HIV
prevalence in the general population.
This year’s crop of incoming college students may
have heard plenty about HIV throughout their lives—
but they still might not make prevention a personal
priority, NPR reports.
At a recent meeting at Howard University in
Washington, DC, UNAIDS director Dr. Peter Piot
urged students to become informed about the virus—
and to realize that the global AIDS epidemic is far
from over. He also addressed DC’s high HIV-
infection rate: One in 20 people there is HIV positive.
According to an American College Health
Association study, HIV prevalence among college
students last year was nearly equal to HIV
prevalence in the general population.
More NEWS |
| NEWS |
 | |  | |  | |  | |  | |  |
November 14, 2007
With the latest advances in treatment, doctors have discovered
that they can successfully neutralise the HIV virus. The so called
'combination therapy' prevents the HIV virus from mutating and
spreading, allowing patients to rebuild their immune system to the
same levels as the rest of the population. To date, it represents the
most significant treatment for patients suffering from HIV.
Professor Jens Lundgren from the Faculty of Health Sciences in
Copenhagen, together with other members of the research group
EuroSIDA, have conducted a study, which demonstrates that the
immune system of all HIV-infected patients can be restored and
normalised. The only stipulation is that patients begin and continue
to follow their course of treatment.
HIV attacks the body's ability to counteract viruses
Viruses are small organisms that have no independent metabolism.
Consequently, when they enter the body they attack living cells and
adopt their metabolism. The influenza virus occupies cells in the
nose, throat and lungs; the mumps attaches itself to the salivary
glands of the ear; while the Polio virus plays on the intestinal tract,
blood and salivary glands. In all these instances, our immune
system attacks and eliminates the invading virus. HIV is so deadly
because the virus attaches itself to a crucial part of the immune
system itself: to the so-called CD4+T lymphocytes, which are white
blood corpuscles that help the immune system to fight infections.
The Hi-virus forms and invades new CD4+T-lymphocytes. Slowly
but surely, the number of healthy CD4+T lymphocytes in the blood
fall, while HIV relentlessly weakens the body's ability to defend itself
from infection. Finally, the immune system erodes to such an extent
that the infected patient is diagnosed with AIDS. The Hi-virus
mutates constantly as it forms and this is why, scientists face a
constant battle to find a cure or a vaccine.
Combination therapy knocks out HIV
Combination therapy prevents the virus from forming and mutating
in human beings. When the virus is halted in its progress, the
number of healthy CD4+T cells begins to rise and patients, who
would otherwise die from HIV, can now survive. The immune system
is rejuvenated and is apparently able to normalise itself, providing
that the combination therapy is maintained. The moment the
immune system begins to improve, the HIV-infected patient can no
longer be said to be suffering from an HIV infection or disease,
already declining in strength.
Resource
medicalnewstodayarticles/
With the latest advances in treatment, doctors have discovered
that they can successfully neutralise the HIV virus. The so called
'combination therapy' prevents the HIV virus from mutating and
spreading, allowing patients to rebuild their immune system to the
same levels as the rest of the population. To date, it represents the
most significant treatment for patients suffering from HIV.
Professor Jens Lundgren from the Faculty of Health Sciences in
Copenhagen, together with other members of the research group
EuroSIDA, have conducted a study, which demonstrates that the
immune system of all HIV-infected patients can be restored and
normalised. The only stipulation is that patients begin and continue
to follow their course of treatment.
HIV attacks the body's ability to counteract viruses
Viruses are small organisms that have no independent metabolism.
Consequently, when they enter the body they attack living cells and
adopt their metabolism. The influenza virus occupies cells in the
nose, throat and lungs; the mumps attaches itself to the salivary
glands of the ear; while the Polio virus plays on the intestinal tract,
blood and salivary glands. In all these instances, our immune
system attacks and eliminates the invading virus. HIV is so deadly
because the virus attaches itself to a crucial part of the immune
system itself: to the so-called CD4+T lymphocytes, which are white
blood corpuscles that help the immune system to fight infections.
The Hi-virus forms and invades new CD4+T-lymphocytes. Slowly
but surely, the number of healthy CD4+T lymphocytes in the blood
fall, while HIV relentlessly weakens the body's ability to defend itself
from infection. Finally, the immune system erodes to such an extent
that the infected patient is diagnosed with AIDS. The Hi-virus
mutates constantly as it forms and this is why, scientists face a
constant battle to find a cure or a vaccine.
Combination therapy knocks out HIV
Combination therapy prevents the virus from forming and mutating
in human beings. When the virus is halted in its progress, the
number of healthy CD4+T cells begins to rise and patients, who
would otherwise die from HIV, can now survive. The immune system
is rejuvenated and is apparently able to normalise itself, providing
that the combination therapy is maintained. The moment the
immune system begins to improve, the HIV-infected patient can no
longer be said to be suffering from an HIV infection or disease,
already declining in strength.
Resource
medicalnewstodayarticles/
© 2007 Abesha Care Inc. All Right Reserved. office@abeshacare.org
More NEWS |
|
| NEWS |
 | |  | |  | |  | |  | |  | |  | |  | |  |